Enablex 7.5mg Tablet
PDF Leaflet Revision Date: 17 February 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of overactive bladder.
Dosage (summary)
Starting dose: 7.5 mg daily, may increase to 15 mg after 2 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP2D6 substrates
Contraindications
- Hypersensitivity
- Urinary retention
- Severe hepatic impairment
Common side effects
- Dry mouth
- Constipation
- Nausea
- Dizziness
Counselling Points
- Take once daily with liquid
- Do not chew or crush tablets
- Monitor for anticholinergic effects
Serious warnings
- Caution in narrow-angle glaucoma
- Risk of urinary retention
Important Disclaimer
The Enablex 7.5mg Tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
